BioNTech SE (BNTX)

NASDAQ HEALTHCARE
$91.49 -1.60% RSI 44 Neutral Add Alert

Moving Averages

SMA 200
$99.00
Price below

Company Profile

BioNTech SE, a biotechnology company, develops and markets immunotherapies for cancer and other infectious diseases. The company is headquartered in Mainz, Germany.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$23.14B
P/E Ratio
None
EPS
$-5.77
Beta
1.324
Dividend Yield
0.00%
52-Week High
$124
52-Week Low
$79.52

Similar stocks in BIOTECHNOLOGY

VRTX
Vertex Pharmaceuticals Inc
RSI 51.0
CRSP
CRISPR Therapeutics AG
RSI 41.0
MRNA
Moderna Inc
RSI 55.0
VKTX
Viking Therapeutics Inc
RSI 59.0
SRPT
Sarepta Therapeutics Inc
RSI 56.0
EDIT
Editas Medicine Inc
RSI 55.0
IOVA
Iovance Biotherapeutics Inc
RSI 53.0
NVAX
Novavax Inc
RSI 51.0
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 49.0
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 52.0

Data last updated: July 13, 2026 at 1:03 AM EDT

Track BNTX for free

Get e-mail RSI alerts when BioNTech SE enters oversold or overbought territory. Free forever.

Add Alert